ImmunityBio is navigating a stark divide. While its commercial engine, driven by the cancer drug Anktiva, is firing on all...

Strategy Inc. has added another 13,927 Bitcoin to its colossal holdings, but the method of financing this latest $1 billion...

The fate of German agricultural and energy group BayWa rests on a precarious convergence of events slated for the final...

Red Cat Holdings is accelerating the development of its autonomous systems ecosystem on multiple fronts, with a series of strategic...

A major scientific review has delivered a timely endorsement for Plug Power Inc.'s strategic shift. A meta-analysis released Sunday by...

Strategy Inc. is navigating a financial paradox. The company, which holds more Bitcoin than any other publicly traded entity, reported...

ImmunityBio's stock is navigating a volatile path, caught between explosive commercial growth for its bladder cancer drug and a rising...

Positive clinical results for a late-stage cancer drug candidate have strengthened BioNTech's strategic pivot away from its pandemic-era business. The...

Xiaomi's stock is caught in a vice, pressured by the very technological revolution it seeks to lead. The company's aggressive...

As broader markets grapple with geopolitical tensions and rising oil prices, shares of Munich-based insurance giant Allianz are demonstrating notable...